Literature DB >> 15386786

Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer.

Bernadine Cimprich1, Heeyoung So, David L Ronis, Christine Trask.   

Abstract

Women treated for breast cancer have shown cognitive deficits with reduced capacity to focus and concentrate or to direct attention. This study examined the relationship between cognitive function prior to any treatment for breast cancer and individual factors including age, education, menopausal status, chronic health problems, and distress. Women newly diagnosed with breast cancer (N=184), ages 27-86 years, were assessed with standardized attention tests, self-reports of effectiveness in cognitive functioning, and measures of distress at about 18 days before surgery. Measured performance on the cognitive tests was not significantly correlated to self-reports of effectiveness in cognitive functioning. Age, education, presence of a chronic health problem, and menopausal status, but not distress, were associated with performance on the cognitive tests. Only age and education, however, were significant (p<0.001) predictors of overall performance on the cognitive tests, when controlling covariates. In contrast, symptom and mood distress significantly (p<0.001) predicted perceptions of effectiveness in cognitive functioning. Thus, different factors were associated with measured performance versus self-reports of cognitive functioning. Individual factors that predispose to lowered effectiveness in cognitive functioning prior to treatment in women newly diagnosed with breast cancer are discussed. 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15386786     DOI: 10.1002/pon.821

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  55 in total

Review 1.  Chemotherapy-related cognitive dysfunction.

Authors:  Jeffrey S Wefel; Sanne B Schagen
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

2.  Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Authors:  Jamie S Myers; Jo A Wick; Jennifer Klemp
Journal:  Support Care Cancer       Date:  2015-04-03       Impact factor: 3.603

3.  Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Authors:  Catherine M Bender; Susan M Sereika; Adam M Brufsky; Christopher M Ryan; Victor G Vogel; Priya Rastogi; Susan M Cohen; Frances E Casillo; Sarah L Berga
Journal:  Menopause       Date:  2007 Nov-Dec       Impact factor: 2.953

4.  Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.

Authors:  Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

5.  Predictors of initial levels and trajectories of anxiety in women before and for 6 months after breast cancer surgery.

Authors:  Marianna Kyranou; Kathleen Puntillo; Laura B Dunn; Bradley E Aouizerat; Steven M Paul; Bruce A Cooper; John Neuhaus; Claudia West; Marylin Dodd; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2014 Nov-Dec       Impact factor: 2.592

6.  Differences in morning and evening fatigue in oncology patients and their family caregivers.

Authors:  Anand Dhruva; Bradley E Aouizerat; Bruce Cooper; Steven M Paul; Marylin Dodd; Claudia West; William Wara; Kathryn Lee; Laura B Dunn; Dale J Langford; John D Merriman; Christina Baggott; Janine Cataldo; Christine Ritchie; Kord Kober; Heather Leutwyler; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2013-09-05       Impact factor: 2.398

7.  Anxiety profiles are associated with stress, resilience and symptom severity in outpatients receiving chemotherapy.

Authors:  Kate Oppegaard; Carolyn S Harris; Joosun Shin; Steven M Paul; Bruce A Cooper; Jon D Levine; Yvette P Conley; Marilyn Hammer; Frances Cartwright; Fay Wright; Laura Dunn; Kord M Kober; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2021-06-26       Impact factor: 3.603

Review 8.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

9.  Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy.

Authors:  Inger Utne; Bruce A Cooper; Christine Ritchie; Melisa Wong; Laura B Dunn; Borghild Loyland; Ellen Karine Grov; Marilyn J Hammer; Steven M Paul; Jon D Levine; Yvette P Conley; Kord M Kober; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2020-08-03       Impact factor: 2.398

10.  Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers.

Authors:  John D Merriman; Bradley E Aouizerat; Dale J Langford; Bruce A Cooper; Christina R Baggott; Janine K Cataldo; Anand Dhruva; Laura Dunn; Claudia West; Steven M Paul; Christine S Ritchie; Patrick S Swift; Christine Miaskowski
Journal:  Biol Res Nurs       Date:  2013-03-11       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.